EP2893040

GUARDANT HEALTH
Application Number
EP13834427A
Filing Date
Sep 4, 2013
Status
Revoked
Jan 10, 2025
Grant Date
Jan 2, 2019
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Biblio Summary

The patent EP2893040B1 was granted on Jan 2, 2019 by Guardant Health The patent is currently Revoked.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GRUNECKER PATENT UND RECHTSANWALTE PARTG MBBOct 2, 2019ADMISSIBLE
STRAWMANOct 2, 2019ADMISSIBLE
FOUNDATION MEDICINEOct 2, 2019WITHDRAWN
PERSONAL GENOME DIAGNOSTICSOct 2, 2019WITHDRAWN

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionWO2012142213
N/A
OppositionWO2013123442
N/A
OppositionWO2013142389
N/A
OppositionWO2014039556
N/A
OppositionUS2011160078
N/A
OppositionUS2012165202
N/A
OppositionWO2012042374
N/A
OppositionWO2012129363
N/A
OppositionUS2013137588
N/A
OppositionUS8481292
N/A
OppositionUS2013210643
N/A
OppositionWO2013138510
N/A

Access Full Citation Information

Get a free, in-depth citation report including examiner, opposition, and international search citations.

Get Free Citation Report

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.